APONTIS PHARMA AG (DE:APPH)
:APPH
Germany Market

APONTIS PHARMA AG (APPH) Stock Forecast & Price Target

Compare
6 Followers
See the Price Targets and Ratings of:

APPH Financial Forecast

APPH Earnings Forecast

Currently, no earnings data available.
Currently, no earnings data available.

APPH Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Warburg Research
€10
Sell
-13.79%
Downside
Reiterated
11/19/24
APONTIS PHARMA AG (APPH) Receives a Sell from Warburg Research
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Warburg Research
€10
Sell
-13.79%
Downside
Reiterated
11/19/24
APONTIS PHARMA AG (APPH) Receives a Sell from Warburg Research
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

APPH Analyst Recommendation Trends

Rating
Nov 23
Jan 24
Feb 24
Apr 24
Nov 24
Strong Buy
4
3
3
3
2
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
1
Strong Sell
0
0
0
0
0
total
4
3
3
3
3
In the current month, APPH has received 2 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. APPH average Analyst price target in the past 3 months is €10.00.
Each month's total comprises the sum of three months' worth of ratings.

APPH Stock Forecast FAQ

What is DE:APPH’s average 12-month price target, according to analysts?
Based on analyst ratings, APONTIS PHARMA AG’s 12-month average price target is €10.00.
    What is DE:APPH’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for DE:APPH, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is APONTIS PHARMA AG a Buy, Sell or Hold?
        APONTIS PHARMA AG has a consensus rating of Moderate Sell, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is APONTIS PHARMA AG’s share price target?
          The average share price target for APONTIS PHARMA AG is €10.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is €10.00 ,and the lowest forecast is €10.00. The average share price target represents -13.79% Decrease from the current price of €11.6.
            What do analysts say about APONTIS PHARMA AG?
            APONTIS PHARMA AG’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of APONTIS PHARMA AG?
              To buy shares of DE:APPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis